H. R. 2617—1603 
(2) (a) EPA-initiated amendments shall not be charged registration service fees. 
(b) Registrant-initiated fast-track amendments are to be completed within the 
timelines specified in section 3(c)(3)(B) and are not subject to registration service 
fees. (c) Registrant-initiated fast-track amendments handled by the Antimicrobials 
Division are to be completed within the timelines specified in section 3(h) and are 
not subject to registration service fees. (d) Registrant initiated amendments sub-
mitted by notification under Pesticide Registration (PR) Notices, such as PR Notice 
98-10, continue under PR Notice timelines and are not subject to registration service 
fees. (e) Submissions with data and requiring data review are subject to registration 
service fees. 
(3) Where the action involves approval of a new or amended label, on or before the 
end date of the decision review time, the Agency shall provide to the applicant a 
draft accepted label, including any changes made by the Agency that differ from the 
applicant-submitted label and relevant supporting data reviewed by the Agency. The 
applicant will notify the Agency that the applicant either (a) agrees to all of the 
terms associated with the draft accepted label as amended by the Agency and re-
quests that it be issued as the accepted final Agency-stamped label; or (b) does not 
agree to one or more of the terms of the draft accepted label as amended by the 
Agency and requests additional time to resolve the difference(s); or (c) withdraws 
the application without prejudice for subsequent resubmission, but forfeits the asso-
ciated registration service fee. For cases described in (b), the applicant shall have up 
to 30 calendar days to reach agreement with the Agency on the final terms of the 
Agency-accepted label. If the applicant agrees to all of the terms of the accepted 
label as in (a), including upon resolution of differences in (b), the Agency shall pro-
vide an accepted final Agency-stamped label to the registrant within 2 business 
days following the registrant’s written or electronic confirmation of agreement to the 
Agency. 
(4) If the Administrator determines that endangered species analysis is required 
for this action, using guidance finalized according to section 33(c)(3)(B) for this spe-
cific type of action, the decision review time can be extended for endangered species 
assessment one time only for up to 50%, upon written notification to the applicant, 
prior to completion of the technical screening. To the extent practicable, any reason 
for renegotiation should be resolved during the same extension. 
‘‘TABLE 15. — BIOPESTICIDES AND POLLUTION PREVEN-
TION 
DIVISION 
(BPPD) 
— 
STRAIGHT-CHAIN 
LEPIDOPTERAN PHEROMONES (SCLP) 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B690 
147 
SCLP; new active in-
gredient; food or 
non-food use. (2) (6) 
(7) 
3,662 
B700 
148 
SCLP; Experimental 
Use Permit applica-
tion; new active in-
gredient or new use. 
(6) (7) 
1,833 
B701 
149 
SCLP; Extend or 
amend Experi-
mental Use Permit. 
(6) (7) 
1,833
H. R. 2617—1604 
‘‘TABLE 15. — BIOPESTICIDES AND POLLUTION PREVEN-
TION 
DIVISION 
(BPPD) 
— 
STRAIGHT-CHAIN 
LEPIDOPTERAN PHEROMONES (SCLP)—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B710 
150 
SCLP; new product; 
registered source of 
active ingredient(s); 
identical or sub-
stantially similar in 
composition and use 
to a registered prod-
uct; no change in an 
established toler-
ance or tolerance 
exemption; no data 
submission or data 
matrix (or only 
product chemistry 
data); (Includes 
100% re-pack; re-
pack of registered 
end-use product as 
a manufacturing- 
use product). (3) (6) 
1,833 
B720 
151 
SCLP; new product; 
registered source of 
active ingredient(s); 
no change in an es-
tablished tolerance 
or tolerance exemp-
tion (including non- 
food); Must address 
Product-Specific 
Data Requirements. 
(3) (6) 
1,833 
B721 
152 
SCLP: new product; 
unregistered source 
of active ingredient; 
no change in an es-
tablished tolerance 
or tolerance exemp-
tion (including non- 
food); must address 
Product-Specific 
and Generic Data 
Requirements. (3) 
(6) 
3,836 
B722 
153 
SCLP; new use and/or 
amendment; peti-
tion to establish a 
tolerance or toler-
ance exemption. (4) 
(5) (6) (7) 
3,552
H. R. 2617—1605 
‘‘TABLE 15. — BIOPESTICIDES AND POLLUTION PREVEN-
TION 
DIVISION 
(BPPD) 
— 
STRAIGHT-CHAIN 
LEPIDOPTERAN PHEROMONES (SCLP)—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B730 
154 
SCLP; amendment re-
quiring data sub-
mission. (4) (6) 
1,833 
(1) A decision review time that would otherwise end on a Saturday, Sunday, or 
Federal holiday, will be extended to end on the next business day. 
(2) All requests for new uses (food and/or nonfood) contained in any application for 
a new active ingredient or a first food use are covered by the base fee for that new 
active ingredient or first food use application and retain the same decision time re-
view period as the new active ingredient or first food use application. The applica-
tion must be received by the Agency in one package. The base fee for the category 
covers a maximum of five new products. Each application for an additional new 
product registration and new inert approval that is submitted in the new active in-
gredient application package or first food use application package is subject to the 
registration service fee for a new product or a new inert approval. All such associ-
ated applications that are submitted together will be subject to the new active ingre-
dient or first food use decision review time. In the case of a new active ingredient 
application, until that new active ingredient is approved, any subsequent applica-
tion for another new product containing the same active ingredient or an amend-
ment to the proposed labeling will be deemed a new active ingredient application, 
subject to the registration service fee and decision review time for a new active in-
gredient. In the case of a first food use application, until that first food use is ap-
proved, any subsequent application for an additional new food use or uses will be 
subject to the registration service fee and decision review time for a first food use. 
Any information that (a) was neither requested nor required by the Agency, and (b) 
is submitted by the applicant at the applicant’s initiative to support the application 
after completion of the preliminary technical screening, and (c) is not itself a cov-
ered registration application, must be assessed 25% of the full registration service 
fee for the new active ingredient or first food use application. 
(3) An application for a new end-use product using a source of active ingredient 
that (a) is not yet registered but (b) has an application pending with the Agency for 
review, will be considered an application for a new product with an unregistered 
source of active ingredient. 
(4) (a) EPA-initiated amendments shall not be charged registration service fees. 
(b) Registrant-initiated fast-track amendments are to be completed within the 
timelines specified in section 3(c)(3)(B) and are not subject to registration service 
fees. (c) Registrant-initiated fast-track amendments handled by the Antimicrobials 
Division are to be completed within the timelines specified in section 3(h) and are 
not subject to registration service fees. (d) Registrant initiated amendments sub-
mitted by notification under Pesticide Registration (PR) Notices, such as PR Notice 
98-10, continue under PR Notice timelines and are not subject to registration service 
fees. (e) Submissions with data and requiring data review are subject to registration 
service fees.
H. R. 2617—1606 
(5) Amendment applications to add the new use(s) to registered product labels are 
covered by the base fee for the new use(s). All items in the covered application must 
be submitted together in one package. Each application for an additional new prod-
uct registration and new inert approval(s) that is submitted in the new use applica-
tion package is subject to the registration service fee for a new product or a new 
inert approval. However, if a new use application only proposes to register the new 
use for a new product and there are no amendments in the application, then review 
of one new product application is covered by the new use fee. All such associated ap-
plications that are submitted together will be subject to the new use decision review 
time. Any application for a new product or an amendment to the proposed labeling 
(a) submitted subsequent to submission of the new use application and (b) prior to 
conclusion of its decision review time and (c) containing the same new uses, will be 
deemed a separate new-use application, subject to a separate registration service fee 
and new decision review time for a new use. If the new-use application includes 
non-food (indoor and/or outdoor), and food (outdoor and/or indoor) uses, the appro-
priate fee is due for each type of new use and the longest decision review time ap-
plies to all of the new uses requested in the application. Any information that (a) 
was neither requested nor required by the Agency, and (b) is submitted by the ap-
plicant at the applicant’s initiative to support the application after completion of the 
preliminary technical screening, and (c) is not itself a covered registration applica-
tion, must be assessed 25% of the full registration service fee for the new use appli-
cation. 
(6) Where the action involves approval of a new or amended label, on or before the 
end date of the decision review time, the Agency shall provide to the applicant a 
draft accepted label, including any changes made by the Agency that differ from the 
applicant-submitted label and relevant supporting data reviewed by the Agency. The 
applicant will notify the Agency that the applicant either (a) agrees to all of the 
terms associated with the draft accepted label as amended by the Agency and re-
quests that it be issued as the accepted final Agency-stamped label; or (b) does not 
agree to one or more of the terms of the draft accepted label as amended by the 
Agency and requests additional time to resolve the difference(s); or (c) withdraws 
the application without prejudice for subsequent resubmission, but forfeits the asso-
ciated registration service fee. For cases described in (b), the applicant shall have up 
to 30 calendar days to reach agreement with the Agency on the final terms of the 
Agency-accepted label. If the applicant agrees to all of the terms of the accepted 
label as in (a), including upon resolution of differences in (b), the Agency shall pro-
vide an accepted final Agency-stamped label to the registrant within 2 business 
days following the registrant’s written or electronic confirmation of agreement to the 
Agency. 
(7) If the Administrator determines that endangered species analysis is required 
for this action, using guidance finalized according to section 33(c)(3)(B) for this spe-
cific type of action, the decision review time can be extended for endangered species 
assessment one time only for up to 50%, upon written notification to the applicant, 
prior to completion of the technical screening. To the extent practicable, any reason 
for renegotiation should be resolved during the same extension. 
‘‘TABLE 16. — BIOPESTICIDES AND POLLUTION 
PREVENTION DIVISION (BPPD) — OTHER ACTIONS 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B614 
155 
Pre-application; Con-
ditional Ruling on 
rationales for ad-
dressing a data re-
quirement in lieu of 
data; applicant-ini-
tiated; applies to 
one (1) rationale at 
a time. 
3,627
H. R. 2617—1607 
‘‘TABLE 16. — BIOPESTICIDES AND POLLUTION PREVEN-
TION DIVISION (BPPD) — OTHER ACTIONS—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B682 
156 
Protocol review; appli-
cant initiated; ex-
cludes time for 
Human Studies Re-
view Board review 
(Includes rebuttal of 
protocol review). 
3,487 
B616 
157 
(new) 
Pre-application; Con-
ditional Ruling on a 
non-food use deter-
mination. 
4,715 
B617 
158 
(new) 
Pre-application; bio-
chemical classifica-
tion determination. 
4,715 
(1) A decision review time that would otherwise end on a Saturday, Sunday, or 
Federal holiday, will be extended to end on the next business day. 
‘‘TABLE 17. — BIOPESTICIDES AND POLLUTION PREVEN-
TION 
DIVISION 
(BPPD) 
— 
PLANT-INCORPORATED 
PROTECTANTS (PIP) 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B740 
159 
Experimental Use 
Permit application; 
no petition for toler-
ance/tolerance ex-
emption; includes: 
1. non-food/feed use(s) 
for a new (2) or reg-
istered (3) PIP (12); 
2. food/feed use(s) for 
a new or registered 
PIP with crop de-
struct; 
3. food/feed use(s) for 
a new or registered 
PIP in which an es-
tablished tolerance/ 
tolerance exemption 
exists for the in-
tended use(s). (4) 
(5) (12) 
137,198
H. R. 2617—1608 
‘‘TABLE 17. — BIOPESTICIDES AND POLLUTION PREVEN-
TION 
DIVISION 
(BPPD) 
— 
PLANT-INCORPORATED 
PROTECTANTS (PIP)—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B750 
160 
Experimental Use 
Permit application; 
with a petition to 
establish a tem-
porary or perma-
nent tolerance/toler-
ance exemption for 
the active ingre-
dient. Includes new 
food/feed use for a 
registered (3) PIP. 
(4) (12) 
182,927 
B771 
161 
Experimental Use 
Permit application; 
new (2) PIP; with 
petition to establish 
a temporary toler-
ance/tolerance ex-
emption for the ac-
tive ingredient; 
credit 75% of B771 
fee toward registra-
tion application for 
a new active ingre-
dient that follows. 
(5) (12) 
182,927 
B772 
162 
Application to amend 
or extend a PIP Ex-
perimental Use Per-
mit; no petition 
since the estab-
lished tolerance/tol-
erance exemption 
for the active ingre-
dient is unaffected. 
(12) 
18,296 
B773 
163 
Application to amend 
or extend a PIP Ex-
perimental Use Per-
mit; with petition to 
extend a temporary 
tolerance/tolerance 
exemption for the 
active ingredient. 
(12) 
45,737
H. R. 2617—1617 
‘‘TABLE 17. — BIOPESTICIDES AND POLLUTION PREVEN-
TION 
DIVISION 
(BPPD) 
— 
PLANT-INCORPORATED 
PROTECTANTS (PIP)—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
B930 
192 
(new) 
Application to amend 
or extend a non-PIP 
Emerging Tech-
nologies Experi-
mental Use Permit; 
no petition since the 
established toler-
ance/tolerance ex-
emption for the ac-
tive ingredient is 
unaffected. (12) 
18,296 
B931 
193 
(new) 
Application to amend 
or extend a non-PIP 
Emerging Tech-
nologies Experi-
mental Use Permit; 
with petition to ex-
tend a temporary 
tolerance/tolerance 
exemption for the 
active ingredient. 
(12) 
45,737 
B932 
194 
(new) 
Amendment; applica-
tion to amend a 
non-PIP Emerging 
Technologies reg-
istration. (4) (5) (12) 
18,296 
(1) A decision review time that would otherwise end on a Saturday, Sunday, or 
Federal holiday, will be extended to end on the next business day. 
(2) ‘New PIP’ means a PIP with an active ingredient that has not been registered. 
(3) ‘Registered PIP’ means a PIP with an active ingredient that is currently reg-
istered. 
(4) Transfer registered PIP through conventional breeding for new food/feed use, 
such as from field corn to sweet corn. 
(5) If, during review of the application, it is determined that review by the FIFRA 
Scientific Advisory Panel (SAP) is needed, the applicant will submit an application 
for category B905, which will be processed concurrently, and the decision review 
time for both applications will be the longer of the two associated applications. The 
scientific data involved in this category are complex. EPA often seeks technical ad-
vice from the SAP on risks that pesticides pose to wildlife, farm workers, pesticide 
applicators, non-target species, insect resistance, and novel scientific issues sur-
rounding new technologies. The scientists of the SAP neither make nor recommend 
policy decisions. They provide advice on the science used to make these decisions. 
Their advice is invaluable to the EPA as it strives to protect humans and the envi-
ronment from risks posed by pesticides. Due to the time it takes to schedule and 
prepare for meetings with the SAP, additional time and costs are needed. 
(6) Registered PIPs stacked through conventional breeding. 
(7) Deployment of a registered PIP with a different Insecticide Resistance Man-
agement (IRM) plan (e.g., seed blend).
H. R. 2617—1618 
(8) The negotiated acreage cap will depend upon EPA’s determination of the po-
tential environmental exposure, risk(s) to non-target organisms, and the risk of tar-
geted pest developing resistance to the pesticidal substance. The uncertainty of 
these risks may reduce the allowable acreage, based upon the quantity and type of 
non-target organism data submitted and the lack of insect resistance management 
data, which is usually not required for seed-increase registrations. Registrants are 
encouraged to consult with EPA prior to submission of a registration application in 
this category. 
(9) Application can be submitted prior to or concurrently with an application for 
commercial registration. 
(10) For example, IRM plan modifications that are applicant-initiated. 
(11) (a) EPA-initiated amendments shall not be charged registration service fees. 
(b) Registrant-initiated fast-track amendments are to be completed within the 
timelines specified in section 3(c)(3)(B) and are not subject to registration service 
fees. (c) Registrant-initiated fast-track amendments handled by the Antimicrobials 
Division are to be completed within the timelines specified in section 3(h) and are 
not subject to registration service fees. (d) Registrant initiated amendments sub-
mitted by notification under Pesticide Registration (PR) Notices, such as PR Notice 
98-10, continue under PR Notice timelines and are not subject to registration service 
fees. (e) Submissions with data and requiring data review are subject to registration 
service fees. 
(12) Where the action involves approval of a new or amended label, on or before 
the end date of the decision review time, the Agency shall provide to the applicant a 
draft accepted label, including any changes made by the Agency that differ from the 
applicant-submitted label and relevant supporting data reviewed by the Agency. The 
applicant will notify the Agency that the applicant either (a) agrees to all of the 
terms associated with the draft accepted label as amended by the Agency and re-
quests that it be issued as the accepted final Agency-stamped label; or (b) does not 
agree to one or more of the terms of the draft accepted label as amended by the 
Agency and requests additional time to resolve the difference(s); or (c) withdraws 
the application without prejudice for subsequent resubmission, but forfeits the asso-
ciated registration service fee. For cases described in (b), the applicant shall have up 
to 30 calendar days to reach agreement with the Agency on the final terms of the 
Agency-accepted label. If the applicant agrees to all of the terms of the accepted 
label as in (a), including upon resolution of differences in (b), the Agency shall pro-
vide an accepted final Agency-stamped label to the registrant within 2 business 
days following the registrant’s written or electronic confirmation of agreement to the 
Agency. 
(13) This category does not include genetic modifications in animals not intended 
for use as a pesticide, e.g., genetic modifications in animals intended for food use or 
animals intended for use as companion animals. 
(14) If the Administrator determines that endangered species analysis is required 
for this action, using guidance finalized according to section 33(c)(3)(B) for this spe-
cific type of action, the decision review time can be extended for endangered species 
assessment one time only for up to 50%, upon written notification to the applicant, 
prior to completion of the technical screening. To the extent practicable, any reason 
for renegotiation should be resolved during the same extension. 
‘‘TABLE 18. — INERT INGREDIENTS 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
I001 
195 
Approval of new food 
use inert ingre-
dient. (2) (3) 
38,698 
I002 
196 
Amend currently ap-
proved inert ingre-
dient tolerance or 
exemption from tol-
erance; new data. 
(2) 
10,750
H. R. 2617—1619 
‘‘TABLE 18. — INERT INGREDIENTS—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
I003 
197 
Amend currently ap-
proved inert ingre-
dient tolerance or 
exemption from tol-
erance; no new 
data. (2) 
4,742 
I004 
198 
Approval of new non- 
food use inert ingre-
dient. (2) 
15,803 
I005 
199 
Amend currently ap-
proved non-food use 
inert ingredient 
with new use pat-
tern; new data. (2) 
7,903 
I006 
200 
Amend currently ap-
proved non-food use 
inert ingredient 
with new use pat-
tern; no new data. 
(2) 
4,742 
I007 
201 
Approval of substan-
tially similar non- 
food use inert ingre-
dients when origi-
nal inert is 
compositionally 
similar with similar 
use pattern. (2) 
2,371 
I008 
202 
Approval of new or 
amended polymer 
inert ingredient, 
food use. (2) 
5,374 
I009 
203 
Approval of new or 
amended polymer 
inert ingredient, 
non-food use. (2) 
4,427 
I010 
204 
Petition to amend a 
single tolerance ex-
emption descriptor, 
or single non-food 
use descriptor, to 
add ≤ 10 CASRNs; 
no new data. (2) 
2,371 
I011 
205 
Approval of new food 
use safener with 
tolerance or exemp-
tion from tolerance. 
(2) 
856,631
H. R. 2617—1620 
‘‘TABLE 18. — INERT INGREDIENTS—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
I012 
206 
Approval of new non- 
food use safener. (2) 
595,147 
I013 
207 
Approval of additional 
food use for pre-
viously approved 
safener with toler-
ance or exemption 
from tolerance. (2) 
90,260 
I014 
208 
Approval of additional 
non-food use for 
previously approved 
safener. (2) 
36,074 
I015 
209 
Approval of new ge-
neric data for pre-
viously approved 
food use safener. (2) 
386,589 
I016 
210 
Approval of amend-
ment(s) to tolerance 
and label for pre-
viously approved 
safener. (2) 
79,942 
I017 
211 
(new) 
Add new source of 
previously approved 
safener. 
18,958 
I018 
212 
(new) 
Petition to add one 
approved inert in-
gredient (CASRN) 
to the Commodity 
Inert Ingredient 
List; no data. (4) 
2,371 
(1) A decision review time that would otherwise end on a Saturday, Sunday, or 
Federal holiday, will be extended to end on the next business day. 
(2) If another covered application is submitted that depends upon an application 
to approve an inert ingredient, each application will be subject to its respective reg-
istration service fee. The decision review time for both submissions will be the long-
est of the associated applications. If the application covers multiple ingredients 
grouped by EPA into one chemical class, a single registration service fee will be as-
sessed for approval of those ingredients. 
(3) If EPA data rules are amended to newly require clearance under section 408 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 346a) for an ingredient of an 
antimicrobial product where such ingredient was not previously subject to such a 
clearance, then review of the data for such clearance of such product is not subject 
to a registration service fee for the tolerance action for two years from the effective 
date of the rule. 
(4) Due to low fee and short time frame this category is not eligible for small busi-
ness waivers.
H. R. 2617—1621 
‘‘TABLE 19. — EXTERNAL REVIEW AND MISCELLANEOUS 
ACTIONS 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
M001 
213 
Study protocol requir-
ing Human Studies 
Review Board re-
view as defined in 
40 CFR Part 26 in 
support of a cur-
rently registered ac-
tive ingredient. 
11,378 
M002 
214 
Completed study re-
quiring Human 
Studies Review 
Board review as de-
fined in 40 CFR 
Part 26 in support 
of an active ingre-
dient. (2) 
11,378 
M003 
215 
External technical 
peer review of new 
active ingredient, 
product, or amend-
ment (e.g., consulta-
tion with FIFRA 
Scientific Advisory 
Panel) for an action 
with a decision 
timeframe of less 
than 12 months. 
Applicant initiated 
request based on a 
requirement of the 
Administrator, as 
defined by FIFRA § 
25(d), in support of 
a novel active ingre-
dient, or unique use 
pattern or applica-
tion technology. Ex-
cludes PIP active 
.ingredients. (3) 
91,651
H. R. 2617—1622 
‘‘TABLE 19. — EXTERNAL REVIEW AND MISCELLANEOUS 
ACTIONS—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
M004 
216 
External technical 
peer review of new 
active ingredient, 
product, or amend-
ment (e.g., consulta-
tion with FIFRA 
Scientific Advisory 
Panel) for an action 
with a decision 
timeframe of great-
er than 12 months. 
Applicant initiated 
request based on a 
requirement of the 
Administrator, as 
defined by FIFRA § 
25(d), in support of 
a novel active ingre-
dient, or unique use 
pattern or applica-
tion technology. Ex-
cludes PIP active 
ingredients. (3) 
91,651 
M005 
217 
New Product: Com-
bination, Contains a 
combination of ac-
tive ingredients 
from a registered 
and/or unregistered 
source; conven-
tional, antimicrobial 
and/or biopesticide. 
Requires coordina-
tion with other reg-
ulatory divisions to 
conduct review of 
data, label and/or 
verify the validity of 
existing data as 
cited. Only existing 
uses for each active 
ingredient in the 
combination prod-
uct. (4) (5) (6) 
31,604 
M006 
218 
Request for up to 5 
letters of certifi-
cation (Gold Seal) 
for one actively reg-
istered product (ex-
cludes distributor 
products). (7) 
398
H. R. 2617—1623 
‘‘TABLE 19. — EXTERNAL REVIEW AND MISCELLANEOUS 
ACTIONS—Continued 
EPA 
No. 
New 
CR 
No. 
Action 
Decision 
Review Time 
(Months)(1) 
Registration 
Service Fee 
($) 
M007 
219 
Request to extend Ex-
clusive Use of data 
as provided by 
FIFRA Section 
3(c)(1)(F)(ii). 
7,903 
M008 
220 
Request to grant Ex-
clusive Use of data 
as provided by 
FIFRA Section 
3(c)(1)(F)(vi) for a 
minor use, when a 
FIFRA Section 
2(ll)(2) determina-
tion is required. 
2,371 
M009 
221 
Non-FIFRA Regulated 
Determination; ap-
plicant-initiated, 
per product. 
3,389 
M010 
222 
Conditional ruling on 
pre-application, 
product substantial 
similarity. 
3,389 
M011 
223 
Label amendment to 
add the DfE logo; 
requires data re-
view; no other label 
changes. (8) 
5,230 
M012 
224 
(new) 
Request for up to 5 
letters of certifi-
cation (Certificate of 
Establishment) for 
one actively reg-
istered product or 
one product pro-
duced for export 
(excludes dis-
tributor products). 
(7) 
398 
M013 
225 
(new) 
Cancer reassessment; 
applicant-initiated. 
284,144 
M014 
227 
(new) 
Pre-application nano- 
particle determina-
tion. 
17,424 
(1) A decision review time that would otherwise end on a Saturday, Sunday, or 
Federal holiday, will be extended to end on the next business day. 
(2) Any other covered application that is associated with and dependent on the re-
view by the Human Studies Review Board will be subject to its separate registration 
service fee. The decision review times for the associated actions run concurrently, 
but will end at the date of the latest review time.
H. R. 2617—1624 
(3) Any other covered application that is associated with and dependent on the 
FIFRA Scientific Advisory Panel review will be subject to its separate registration 
service fee. The decision review time for the associated action will be extended by 
the decision review time for the SAP review. 
(4) If another covered application is submitted that depends upon an application 
to approve an inert ingredient, each application will be subject to its respective reg-
istration service fee. The decision review time for both submissions will be the long-
est of the associated applications. If the application covers multiple ingredients 
grouped by EPA into one chemical class, a single registration service fee will be as-
sessed for approval of those ingredients. 
(5) An application for a new end-use product using a source of active ingredient 
that (a) is not yet registered but (b) has an application pending with the Agency for 
review, will be considered an application for a new product with an unregistered 
source of active ingredient. 
(6) Where the action involves approval of a new or amended label, on or before the 
end date of the decision review time, the Agency shall provide to the applicant a 
draft accepted label, including any changes made by the Agency that differ from the 
applicant-submitted label and relevant supporting data reviewed by the Agency. The 
applicant will notify the Agency that the applicant either (a) agrees to all of the 
terms associated with the draft accepted label as amended by the Agency and re-
quests that it be issued as the accepted final Agency-stamped label; or (b) does not 
agree to one or more of the terms of the draft accepted label as amended by the 
Agency and requests additional time to resolve the difference(s); or (c) withdraws 
the application without prejudice for subsequent resubmission, but forfeits the asso-
ciated registration service fee. For cases described in (b), the applicant shall have up 
to 30 calendar days to reach agreement with the Agency on the final terms of the 
Agency-accepted label. If the applicant agrees to all of the terms of the accepted 
label as in (a), including upon resolution of differences in (b), the Agency shall pro-
vide an accepted final Agency-stamped label to the registrant within 2 business 
days following the registrant’s written or electronic confirmation of agreement to the 
Agency. 
(7) Due to low fee and short time frame this category is not eligible for small busi-
ness waivers. 
(8) This category includes amendments the sole purpose of which is to add ‘Design 
for the Environment’ (DfE) (or equivalent terms that do not use ‘safe’ or derivatives 
of ‘safe’) logos to a label. DfE is a voluntary program. A label bearing a DfE logo is 
not considered an Agency endorsement because the ingredients in the qualifying 
product must meet objective, scientific criteria established and widely publicized by 
EPA.’’. 
SEC. 707. INFORMATION. 
Not later than 180 days after the date of enactment of this 
title, the Administrator of the Environmental Protection Agency 
shall post on a single webpage of the website of the Environmental 
Protection Agency aggregated information on pesticide regulation 
under the Federal Insecticide, Fungicide, and Rodenticide Act (7 
U.S.C. 136 et seq.), including— 
(1) all guidance relating to risk assessment, risk mitigation, 
benefits assessments, and cost-benefit balancing; 
(2) hyperlinks to resources, including the Department of 
Agriculture’s ‘‘national list of allowed and prohibited sub-
stances’’ for organic crop and livestock production; 
(3) biopesticides and pesticides exempt pursuant to section 
25(b) of the Federal Insecticide, Fungicide, and Rodenticide 
Act (7 U.S.C. 136w(b)); and 
(4) integrated pest management principles developed under 
section 28(c) of such Act (7 U.S.C. 136w–3(c)), including tech-
nical assistance for implementation of those principles. 
SEC. 708. IMPLEMENTATION DATES WITH RESPECT TO FEES. 
(a) FEE INCREASES.— 
(1) REGISTRATION SERVICE FEES.—With respect to amend-
ments made by this title to increase registration service fees 
specified in section 33 of the Federal Insecticide, Fungicide, 
and Rodenticide Act (7 U.S.C. 136w–8), such increases shall
H. R. 2617—1625 
not be effective until the date that is 60 days after the date 
of the enactment of this title, regardless of whether such section 
33 specifies (as so amended) that such increases are effective 
for fiscal year 2023. 
(2) MAINTENANCE
FEES.—With respect to amendments 
made by this title to increase the amount of maintenance 
fees to be collected under section 4(i) of the Federal Insecticide, 
Fungicide, and Rodenticide Act (7 U.S.C. 136a–1(i)), such 
increases shall be effective beginning on October 1, 2022. 
(b) SET-ASIDES.—With respect to any set-asides specified in 
subsection (i) or (k) of section 4 of the Federal Insecticide, Fungicide, 
and Rodenticide Act (7 U.S.C. 136a–1), such set-asides shall be 
effective beginning on October 1, 2022. 
Subtitle B—Other Matters Relating to 
Pesticides 
SEC. 711. REGISTRATION REVIEW DEADLINE EXTENSION. 
(a) IN GENERAL.—Notwithstanding section 3(g)(1)(A)(iii)(I) of 
the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 
136a(g)(1)(A)(iii)(I)), the Administrator of the Environmental Protec-
tion Agency (referred to in this section as the ‘‘Administrator’’) 
shall complete the initial registration review of each pesticide or 
pesticide case covered by that section not later than October 1, 
2026. 
(b) INTERIM REGISTRATION REVIEW DECISION REQUIREMENTS.— 
(1) DEFINITION OF COVERED INTERIM REGISTRATION REVIEW 
DECISION.—In this subsection, the term ‘‘covered interim reg-
istration review decision’’ means an interim registration review 
decision— 
(A) that is associated with an initial registration review 
described in subsection (a); 
(B) that is noticed in the Federal Register during the 
period beginning on the date of enactment of this Act 
and ending on October 1, 2026; and 
(C) for which the Administrator has not, as of the 
date on which the decision is noticed in the Federal Reg-
ister, made effects determinations or completed any nec-
essary consultation under section 7(a)(2) of the Endangered 
Species Act of 1973 (16 U.S.C. 1536(a)(2)). 
(2) REQUIREMENTS.—Any covered interim registration 
review decision shall include, where applicable, measures to 
reduce the effects of the applicable pesticide on— 
(A) species listed under the Endangered Species Act 
of 1973 (16 U.S.C. 1531 et seq.); or 
(B) any designated critical habitat. 
(3) CONSULTATION.—In developing measures described in 
paragraph (2), the Administrator shall take into account the 
input received from the Secretary of Agriculture and other 
members of the interagency working group established under 
section 3(c)(11) of the Federal Insecticide, Fungicide, and 
Rodenticide Act (7 U.S.C. 136a(c)(11)).
H. R. 2617—1626 
DIVISION II—PREGNANT WORKERS 
SEC. 101. SHORT TITLE. 
This division may be cited as the ‘‘Pregnant Workers Fairness 
Act’’. 
SEC. 102. DEFINITIONS. 
As used in this division— 
(1) the term ‘‘Commission’’ means the Equal Employment 
Opportunity Commission; 
(2) the term ‘‘covered entity’’— 
(A) has the meaning given the term ‘‘respondent’’ in 
section 701(n) of the Civil Rights Act of 1964 (42 U.S.C. 
2000e(n)); and 
(B) includes— 
(i) an employer, which means a person engaged 
in industry affecting commerce who has 15 or more 
employees as defined in section 701(b) of title VII of 
the Civil Rights Act of 1964 (42 U.S.C. 2000e(b)); 
(ii) an employing office, as defined in section 101 
of the Congressional Accountability Act of 1995 (2 
U.S.C. 1301) and section 411(c) of title 3, United States 
Code; 
(iii) an entity employing a State employee 
described in section 304(a) of the Government 
Employee Rights Act of 1991 (42 U.S.C. 2000e–16c(a)); 
and 
(iv) an entity to which section 717(a) of the Civil 
Rights Act of 1964 (42 U.S.C. 2000e–16(a)) applies; 
(3) the term ‘‘employee’’ means— 
(A) an employee (including an applicant), as defined 
in section 701(f) of the Civil Rights Act of 1964 (42 U.S.C. 
2000e(f)); 
(B) a covered employee (including an applicant), as 
defined in section 101 of the Congressional Accountability 
Act of 1995 (2 U.S.C. 1301), and an individual described 
in section 201(d) of that Act (2 U.S.C. 1311(d)); 
(C) a covered employee (including an applicant), as 
defined in section 411(c) of title 3, United States Code; 
(D) a State employee (including an applicant) described 
in section 304(a) of the Government Employee Rights Act 
of 1991 (42 U.S.C. 2000e–16c(a)); or 
(E) an employee (including an applicant) to which sec-
tion 717(a) of the Civil Rights Act of 1964 (42 U.S.C. 
2000e–16(a)) applies; 
(4) the term ‘‘known limitation’’ means physical or mental 
condition related to, affected by, or arising out of pregnancy, 
childbirth, or related medical conditions that the employee or 
employee’s representative has communicated to the employer 
whether or not such condition meets the definition of disability 
specified in section 3 of the Americans with Disabilities Act 
of 1990 (42 U.S.C. 12102); 
(5) the term ‘‘person’’ has the meaning given such term 
in section 701(a) of the Civil Rights Act of 1964 (42 U.S.C. 
2000e(a));
H. R. 2617—1627 
(6) the term ‘‘qualified employee’’ means an employee or 
applicant who, with or without reasonable accommodation, can 
perform the essential functions of the employment position, 
except that an employee or applicant shall be considered quali-
fied if— 
(A) any inability to perform an essential function is 
for a temporary period; 
(B) the essential function could be performed in the 
near future; and 
(C) the inability to perform the essential function can 
be reasonably accommodated; and 
(7) the terms ‘‘reasonable accommodation’’ and ‘‘undue 
hardship’’ have the meanings given such terms in section 101 
of the Americans with Disabilities Act of 1990 (42 U.S.C. 12111) 
and shall be construed as such terms are construed under 
such Act and as set forth in the regulations required by this 
division, including with regard to the interactive process that 
will typically be used to determine an appropriate reasonable 
accommodation. 
SEC. 103. NONDISCRIMINATION WITH REGARD TO REASONABLE 
ACCOMMODATIONS RELATED TO PREGNANCY. 
It shall be an unlawful employment practice for a covered 
entity to— 
(1) not make reasonable accommodations to the known 
limitations related to the pregnancy, childbirth, or related med-
ical conditions of a qualified employee, unless such covered 
entity can demonstrate that the accommodation would impose 
an undue hardship on the operation of the business of such 
covered entity; 
(2) require a qualified employee affected by pregnancy, 
childbirth, or related medical conditions to accept an accommo-
dation other than any reasonable accommodation arrived at 
through the interactive process referred to in section 102(7); 
(3) deny employment opportunities to a qualified employee 
if such denial is based on the need of the covered entity to 
make reasonable accommodations to the known limitations 
related to the pregnancy, childbirth, or related medical condi-
tions of the qualified employee; 
(4) require a qualified employee to take leave, whether 
paid or unpaid, if another reasonable accommodation can be 
provided to the known limitations related to the pregnancy, 
childbirth, or related medical conditions of the qualified 
employee; or 
(5) take adverse action in terms, conditions, or privileges 
of employment against a qualified employee on account of the 
employee requesting or using a reasonable accommodation to 
the known limitations related to the pregnancy, childbirth, 
or related medical conditions of the employee. 
SEC. 104. REMEDIES AND ENFORCEMENT. 
(a) EMPLOYEES COVERED BY TITLE VII OF THE CIVIL RIGHTS 
ACT OF 1964.— 
(1) IN GENERAL.—The powers, remedies, and procedures 
provided in sections 705, 706, 707, 709, 710, and 711 of the 
Civil Rights Act of 1964 (42 U.S.C. 2000e–4 et seq.) to the 
Commission, the Attorney General, or any person alleging a 
violation of title VII of such Act (42 U.S.C. 2000e et seq.)
H. R. 2617—1630 
remedies, and procedures this division provides to the Commis-
sion, the Attorney General, the Librarian of Congress, or any 
person alleging such practice. 
(3) DAMAGES.—The powers, remedies, and procedures pro-
vided in section 1977A of the Revised Statutes (42 U.S.C. 
1981a), including the limitations contained in subsection (b)(3) 
of such section 1977A, shall be the powers, remedies, and 
procedures this division provides to the Commission, the 
Attorney General, the Librarian of Congress, or any person 
alleging such practice (not an employment practice specifically 
excluded from coverage under section 1977A(a)(1) of the Revised 
Statutes (42 U.S.C. 1981a(a)(1))). 
(f) PROHIBITION AGAINST RETALIATION.— 
(1) IN GENERAL.—No person shall discriminate against any 
employee because such employee has opposed any act or prac-
tice made unlawful by this division or because such employee 
made a charge, testified, assisted, or participated in any manner 
in an investigation, proceeding, or hearing under this division. 
(2) PROHIBITION AGAINST COERCION.—It shall be unlawful 
to coerce, intimidate, threaten, or interfere with any individual 
in the exercise or enjoyment of, or on account of such individual 
having exercised or enjoyed, or on account of such individual 
having aided or encouraged any other individual in the exercise 
or enjoyment of, any right granted or protected by this division. 
(3) REMEDY.—The remedies and procedures otherwise pro-
vided for under this section shall be available to aggrieved 
individuals with respect to violations of this subsection. 
(g) LIMITATION.—Notwithstanding subsections (a)(3), (b)(3), 
(c)(3), (d)(3), and (e)(3), if an unlawful employment practice involves 
the provision of a reasonable accommodation pursuant to this divi-
sion or regulations implementing this division, damages may not 
be awarded under section 1977A of the Revised Statutes (42 U.S.C. 
1981a) if the covered entity demonstrates good faith efforts, in 
consultation with the employee with known limitations related to 
pregnancy, childbirth, or related medical conditions who has 
informed the covered entity that accommodation is needed, to iden-
tify and make a reasonable accommodation that would provide 
such employee with an equally effective opportunity and would 
not cause an undue hardship on the operation of the covered entity. 
SEC. 105. RULEMAKING. 
(a) EEOC RULEMAKING.—Not later than 1 year after the date 
of enactment of this Act, the Commission shall issue regulations 
in an accessible format in accordance with subchapter II of chapter 
5 of title 5, United States Code, to carry out this division. Such 
regulations shall provide examples of reasonable accommodations 
addressing known limitations related to pregnancy, childbirth, or 
related medical conditions. 
(b) OCWR RULEMAKING.— 
(1) IN
GENERAL.—Not later than 6 months after the 
Commission issues regulations under subsection (a), the Board 
(as defined in section 101 of the Congressional Accountability 
Act of 1995 (2 U.S.C. 1301)) shall (in accordance with section 
304 of the Congressional Accountability Act of 1995 (2 U.S.C. 
1384)), issue regulations to implement the provisions of this 
division made applicable to employees described in section 
102(3)(B), under section 104(b).
H. R. 2617—1631 
(2) PARALLEL WITH AGENCY REGULATIONS.—The regulations 
issued under paragraph (1) shall be the same as substantive 
regulations issued by the Commission under subsection (a) 
except to the extent that the Board may determine, for good 
cause shown and stated together with the regulations issued 
under paragraph (1) that a modification of such substantive 
regulations would be more effective for the implementation 
of the rights and protection under this division. 
SEC. 106. WAIVER OF STATE IMMUNITY. 
A State shall not be immune under the 11th Amendment to 
the Constitution from an action in a Federal or State court of 
competent jurisdiction for a violation of this division. In any action 
against a State for a violation of this division, remedies (including 
remedies both at law and in equity) are available for such a violation 
to the same extent as such remedies are available for such a 
violation in an action against any public or private entity other 
than a State. 
SEC. 107. RELATIONSHIP TO OTHER LAWS. 
(a) IN GENERAL.—Nothing in this division shall be construed— 
(1) to invalidate or limit the powers, remedies, and proce-
dures under any Federal law or law of any State or political 
subdivision of any State or jurisdiction that provides greater 
or equal protection for individuals affected by pregnancy, child-
birth, or related medical conditions; or 
(2) by regulation or otherwise, to require an employer- 
sponsored health plan to pay for or cover any particular item, 
procedure, or treatment or to affect any right or remedy avail-
able under any other Federal, State, or local law with respect 
to any such payment or coverage requirement. 
(b) RULE OF CONSTRUCTION.—This division is subject to the 
applicability to religious employment set forth in section 702(a) 
of the Civil Rights Act of 1964 (42 U.S.C. 2000e–1(a)). 
SEC. 108. SEVERABILITY. 
If any provision of this division or the application of that 
provision to particular persons or circumstances is held invalid 
or found to be unconstitutional, the remainder of this division 
and the application of that provision to other persons or cir-
cumstances shall not be affected. 
SEC. 109. EFFECTIVE DATE. 
This division shall take effect on the date that is 180 days 
after the date of enactment of this Act. 
DIVISION JJ—NORTH ATLANTIC RIGHT 
WHALES 
TITLE I—NORTH ATLANTIC RIGHT 
WHALES AND REGULATIONS 
SEC. 101. NORTH ATLANTIC RIGHT WHALES AND REGULATIONS. 
(a) IN GENERAL.—Notwithstanding any other provision of law 
except as provided in subsection (b), for the period beginning on 
the date of enactment of this Act and ending on December 31,
H. R. 2617—1632 
2028, the Final Rule amending the regulations implementing the 
Atlantic Large Whale Take Reduction Plan (86 Fed. Reg. 51970) 
shall be deemed sufficient to ensure that the continued Federal 
and State authorizations of the American lobster and Jonah crab 
fisheries are in full compliance with the Marine Mammal Protection 
Act of 1972 (16 U.S.C. 1361 et seq.) and the Endangered Species 
Act of 1973 (16 U.S.C. 1531 et seq.). The National Marine Fisheries 
Service shall— 
(1) throughout the period described in the preceding sen-
tence, in consultation with affected States and fishing industry 
participants, promote the innovation and adoption of gear tech-
nologies in the fisheries described in the preceding sentence, 
in order to implement additional whale protection measures 
by December 31, 2028; 
(2) promulgate new regulations for the American lobster 
and Jonah crab fisheries consistent with the Marine Mammal 
Protection Act of 1972 (16 U.S.C. 1361 et seq.) and the Endan-
gered Species Act of 1973 (16 U.S.C. 1531 et seq.) that take 
effect by December 31, 2028, utilizing existing and innovative 
gear technologies, as appropriate; and 
(3) in consultation with affected States, submit an annual 
report to Congress on the status of North Atlantic Right 
Whales, the actions taken and plans to implement measures 
expected to not exceed Potential Biological Removal by 
December 31, 2028, the amount of serious injury and mortality 
by fishery and country, and the proportion of the American 
lobster and Jonah crab fisheries that have transitioned to 
innovative gear technologies that reduce harm to the North 
Atlantic Right Whale. 
(b) EXCEPTION.—The provisions of subsection (a) shall not apply 
to an existing emergency rule, or any action taken to extend or 
make final an emergency rule that is in place on the date of 
enactment of this Act, affecting lobster and Jonah crab. 
TITLE II—GRANT AUTHORITY 
SEC. 201. CONSERVATION AND MITIGATION ASSISTANCE. 
(a) ASSISTANCE.— 
(1) IN GENERAL.—Not later than 180 days after the date 
of enactment of this Act, the Secretary of Commerce, acting 
through the Under Secretary of Commerce for Oceans and 
Atmosphere (in this title referred to as the ‘‘Under Secretary’’) 
shall establish a program to provide competitive financial 
assistance, on an annual basis, and cooperative agreements 
including multiyear grants and direct payment, to eligible enti-
ties for eligible uses, such as projects designed to reduce the 
lethal and sub-lethal effects of human activities on North 
Atlantic right whales. 
(2) USE
OF
EXISTING
AUTHORITIES.—Assistance provided 
under this section shall be carried out in a manner consistent 
with authorities available to the Secretary under the Endan-
gered Species Act of 1973 (16 U.S.C. 1531 et seq.) and the 
Marine Mammal Protection Act of 1972 (16 U.S.C. 1361 et 
seq.). 
(3) COOPERATIVE AGREEMENTS.—The Under Secretary may 
enter into cooperative agreements with the National Fish and
H. R. 2617—1633 
Wildlife Foundation established by the National Fish and Wild-
life Foundation Establishment Act (16 U.S.C. 3701 et seq.) 
to carry out this title. 
(b) ELIGIBLE ENTITIES.—An entity is an eligible entity for pur-
poses of assistance awarded under subsection (a) if the entity is— 
(1) a relevant port authority for a port; 
(2) a relevant State, regional, local, or Tribal government; 
(3) any other individual or entity, as determined appro-
priate by the Under Secretary, including— 
(A) an owner or operator of a vessel, as defined under 
section 3 of title 1, United States Code; and 
(B) participants within sectors of the maritime 
industry, such as boating, shipping, fishing, fishing gear 
and rope manufacturing, and other maritime activities; 
(4) a nonprofit organization or research institution with 
expertise in commercial fisheries, gear innovation, and North 
Atlantic right whale conservation; or 
(5) a consortium of entities described in paragraphs (1) 
through (4). 
(c) ELIGIBLE USES.—Assistance awarded under subsection (a) 
may be used to develop, assess, and carry out activities that reduce 
human induced threats to North Atlantic right whales, including— 
(1) funding research to identify, deploy, or test innovative 
gear technologies; 
(2) subsidizing acquisition of innovative gear technologies 
to improve adoption of those technologies by fisheries partici-
pants, which may include direct payment to fisheries partici-
pants; 
(3) training for fisheries participants to improve deploy-
ment, safety, and adoption of innovative gear technologies; 
(4) funding for monitoring necessary to support dynamic 
management of fisheries, vessel traffic, or other needs; and 
(5) other uses as determined by the Under Secretary in 
consultation with relevant eligible entities. 
(d) PRIORITY.—In determining whether to fund project proposals 
under this section, the Under Secretary shall prioritize projects— 
(1) with a substantial likelihood of reducing lethal and 
sub-lethal effects on North Atlantic right whales from fishing 
gear entanglements or vessel collisions; 
(2) that include cooperation with fishing industry partici-
pants or other private sector stakeholders; and 
(3) that demonstrate, or have the potential to provide, 
economic benefits to small businesses based in the United 
States. 
(e) PROHIBITED USES.— 
(1) IN
GENERAL.—Except as provided in paragraph (2), 
funds awarded under this section may not be used to distribute 
resources to an entity or individual that is not a United States 
person (as defined in section 7701(a)(3) of the Internal Revenue 
Code of 1986). 
(2) EXCEPTION.—Funds awarded under this section may 
be used to distribute resources to a partnership that includes 
an entity or individual that is not a United States person 
(as defined in section 7701(a)(30) of the Internal Revenue Code 
of 1986) if the resources are distributed directly to a partner 
in the partnership that is a United States person (as so defined). 
(f) PROJECT REPORTING.—